Pro-Dex (PDEX) 10-Q 6 Feb 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Dec. 31, 2013	Jan. 31, 2014
Document And Entity Information	'	'
Entity Registrant Name	'PRO DEX INC	'
Entity Central Index Key	'0000788920	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--06-30	'
Entity a Well-known Seasoned Issuer	'No	'
Entity a Voluntary Filer	'No	'
Entity's Reporting Status Current	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	3,342,321
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Current assets:	'	'
Cash and cash equivalents	$1,554,000	$1,680,000
Accounts receivable, net of allowance for doubtful accounts of $31,000 at December 31, 2013 and $24,000 at June 30, 2013	1,580,000	1,339,000
Unbilled receivables	611,000	244,000
Other current receivables	43,000	32,000
Inventories	3,552,000	3,834,000
Prepaid expenses	168,000	157,000
Income taxes receivable	7,000	2,000
Deferred income taxes	60,000	59,000
Total current assets	7,575,000	7,347,000
Investments	903,000	370,000
Equipment and leasehold improvements, net	1,794,000	2,065,000
Real estate held for sale	'	733,000
Intangibles	40,000	'
Other assets	77,000	80,000
Total assets	10,389,000	10,595,000
Current liabilities:	'	'
Accounts payable	626,000	844,000
Accrued expenses	1,089,000	1,276,000
Deferred revenue	247,000	141,000
Income taxes payable	48,000	48,000
Capital lease obligations	7,000	5,000
Total current liabilities	2,017,000	2,314,000
Non-current liabilities:	'	'
Deferred income taxes	60,000	59,000
Deferred rent	253,000	270,000
Capital lease obligations	12,000	15,000
Total non-current liabilities	325,000	344,000
Total liabilities	2,342,000	2,658,000
Commitments and contingencies	'	'
Shareholders' equity:	'	'
Common shares; no par value; 50,000,000 shares authorized; 3,342,321 and 3,348,184 shares issued and outstanding at December 31, 2013 and June 30, 2013, respectively	17,044,000	17,012,000
Accumulated other comprehensive income	209,000	5,000
Accumulated deficit	-9,206,000	-9,080,000
Total shareholders' equity	8,047,000	7,937,000
Total liabilities and shareholders' equity	$10,389,000	$10,595,000

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Statement of Financial Position [Abstract]	'	'
Accounts receivable, allowance for doubtful accounts (in dolllars)	$31,000	$24,000
Common shares, no par value (in dollars per share)	'	'
Common shares, shares authorized	50,000,000	50,000,000
Common shares, shares issued	3,342,321	3,348,184
Common shares, shares outstanding	3,342,321	3,348,184

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]	'	'	'	'
Net sales	$2,640,000	$3,007,000	$5,194,000	$6,468,000
Cost of sales	2,091,000	1,974,000	3,700,000	4,199,000
Gross profit	549,000	1,033,000	1,494,000	2,269,000
Operating expenses:	'	'	'	'
Selling expenses	139,000	322,000	231,000	596,000
General and administrative expenses	422,000	627,000	878,000	1,234,000
Research and development costs	364,000	464,000	740,000	870,000
Total operating expenses	925,000	1,413,000	1,849,000	2,700,000
Loss from continuing operations before items below	-376,000	-380,000	-355,000	-431,000
Other expense (income):	'	'	'	'
Interest expense	2,000	'	4,000	-6,000
Interest income	-10,000	'	-10,000	'
Loss from disposal of equipment	6,000	'	6,000	'
Total other expense (income)	-2,000	'	'	-6,000
Loss from continuing operations before benefit from income taxes	-374,000	-380,000	-355,000	-437,000
Benefit from income taxes	-36,000	-16,000	-35,000	-19,000
Loss from continuing operations	-338,000	-364,000	-320,000	-418,000
Income from discontinued operations, net of provision for income taxes	'	16,000	194,000	53,000
Net loss	-338,000	-348,000	-126,000	-365,000
Other comprehensive income, net of tax	'	'	'	'
Unrealized gain from marketable equity investments	148,000	'	204,000	'
Total other comprehensive income	148,000	'	204,000	'
Comprehensive loss	($190,000)	($348,000)	$78,000	($365,000)
Loss from continuing operations	'	'	'	'
Basic (in dollars per share)	($0.10)	($0.11)	($0.10)	($0.13)
Diluted (in dollars per share)	($0.10)	($0.11)	($0.10)	($0.13)
Income from discontinued operations	'	'	'	'
Basic (in dollars per share)	'	'	$0.06	$0.02
Diluted (in dollars per share)	'	'	$0.06	$0.02
Net loss	'	'	'	'
Basic (in dollars per share)	($0.10)	($0.11)	($0.04)	($0.11)
Diluted (in dollars per share)	($0.10)	($0.11)	($0.04)	($0.11)
Weighted average shares outstanding - basic (in shares)	3,343,499	3,319,180	3,344,098	3,299,379
Weighted average shares outstanding - diluted (in shares)	3,343,499	3,319,180	3,344,098	3,299,379

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]	'	'	'	'
Income taxes related to the income from discontinued operations	$36,000	$21,000	$36,000	$25,000

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net loss	($126,000)	($365,000)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	283,000	298,000
Gain on sale of real estate held for sale	-167,000	'
Allowance for doubtful accounts	7,000	-3,000
Share-based compensation	31,000	65,000
Changes in:	'	'
Accounts receivable and other current receivables	-259,000	440,000
Unbilled receivables	-367,000	'
Inventories	282,000	-724,000
Prepaid expenses and other assets	-8,000	-65,000
Accounts payable, accrued expenses and deferred rent	-422,000	-512,000
Deferred revenue	106,000	36,000
Income taxes receivable and payable	-6,000	39,000
Net cash used in operating activities	-646,000	-791,000
Cash flows from investing activities:	'	'
Purchase of investments	-329,000	'
Purchases of equipment	-15,000	-48,000
Proceeds from sale of real estate held for sale	900,000	'
Proceeds from sale of equipment	6,000	'
Increase in intangibles	-40,000	'
Net cash provided by (used in) investing activities	522,000	-48,000
Cash flows from financing activities:	'	'
Proceeds from exercise of stock options	'	50,000
Principal payments on capital lease and bank term loan	-2,000	-774,000
Net cash used in financing activities	-2,000	-724,000
Net decrease in cash	-126,000	-1,563,000
Cash, beginning of period	1,680,000	4,112,000
Cash, end of period	1,554,000	2,549,000
Supplemental Information	'	'
Cash payments for interest	4,000	9,000
Cash payments for income taxes	$7,000	$5,000

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION	'
	NOTE 1. BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements of Pro-Dex, Inc. (“we”, “us”, “our”, “Pro-Dex” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-K. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These financial statements should be read in conjunction with the consolidated financial statements presented in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2013.
	Recent Accounting Standards
	In August 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” that sets forth circumstances in which an unrecognized tax benefit, generally reflecting the difference between a tax position taken or expected to be taken on a company’s income tax return and the benefit recognized on its financial statements, should be presented in the company’s financial statements as a liability rather than as a reduction of a deferred tax asset. The ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, with early adoption permitted. The adoption of these provisions is not expected to have a material impact on the consolidated financial statements of the Company.

COMPOSITION_OF_CERTAIN_FINANCI

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS	6 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS	'
	NOTE 2. COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS
	Inventories
	Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:
		31-Dec-13		30-Jun-13
	Raw materials / purchased components	$	1,538,000	$	1,640,000
	Work in process		499,000		572,000
	Sub-assemblies / Finished components		1,139,000		1,291,000
	Finished goods		376,000		331,000
	Total inventories	$	3,552,000	$	3,834,000
	Investments
		31-Dec-13		30-Jun-13
	Marketable equity securities	$	903,000	$	370,000
	Investments at December 31, 2013 and June 30, 2013 had an aggregate cost basis of $694,000 and $365,000, respectively, gross unrealized gains aggregating $209,000 and $5,000, respectively, and no unrealized losses.

WARRANTY

WARRANTY	6 Months Ended
	Dec. 31, 2013
Product Warranties Disclosures [Abstract]	'
WARRANTY	'
	NOTE 3. WARRANTY
	The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses, and is included in accrued expenses in the accompanying consolidated balance sheets. As of December 31, 2013 and June 30, 2013, the warranty reserve related to continuing operations amounted to $200,000 and $321,000, respectively. Warranty expenses are included in cost of sales in the accompanying consolidated statements of operations. Changes in estimates to previously established warranty accruals result from current period updates to assumptions regarding repair costs and warranty return rates, and are included in current period warranty expense. Total warranty expense for the three months ended December 31, 2013 and 2012 was $16,000 and $22,000, respectively, and for the six months ended December 31, 2013 and 2012 was $29,000 and $130,000, respectively.
	Information regarding the accrual for warranty costs for the three and six months ended December 31, 2013 and 2012 are as follows:
		Three Months Ended December 31,
		2013			2012
	Balances, beginning of period	$	229,000		$	585,000
	Accruals during the period		47,000			38,000
	Changes in estimates of prior period accruals		(31,000	)		(16,000	)
	Warranty expenditures		(45,000	)		(246,000	)
	Balances, end of period	$	200,000		$	361,000
		Six Months Ended December 31,
		2013			2012
	Balances, beginning of period	$	321,000		$	526,000
	Accruals during the period		96,000			186,000
	Changes in estimates of prior period accruals		(67,000	)		(56,000	)
	Warranty expenditures		(150,000	)		(295,000	)
	Balances, end of period	$	200,000		$	361
	In 2013, we reclassified certain amounts, previously classified as warranty expenditures, to a classification as out-of-warranty repair expenditures, which reclassification had an offsetting effect on the changes in estimates of prior period accruals. The 2012 amounts appearing in the tables above have been reclassified to conform to the 2013 presentation. Such reclassifications had no effect on the accompanying condensed consolidated balance sheets or statements of operations.

NET_INCOME_LOSS_PER_SHARE

NET INCOME (LOSS) PER SHARE	6 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
NET INCOME (LOSS) PER SHARE	'
	NOTE 4. NET INCOME (LOSS) PER SHARE
	The difference in the weighted average shares outstanding used in the calculation of basic and diluted net income (loss) per share for the three and six months ended December 31, 2013 and 2012 is as follows:
		Three Months Ended
		December 31,
		2013			2012
	Numerators for basic and diluted per share data:
	Loss from continuing operations	$	(338,000	)	$	(364,000	)
	Income from discontinued operations		—			16,000
	Net loss	$	(338,000	)	$	(348,000	)
	Denominators for basic and diluted per share data:
	Basic:
	Weighted average common shares outstanding		3,343,499			3,319,180
	Shares used in the computation of basic per share data		3,343,499			3,319,180
	Diluted:
	Shares used in the computation of basic per share data		3,343,499			3,319,180
	Net shares assumed issued using the treasury stock method for outstanding common stock options		—			—
	Shares used in the computation of diluted per share data		3,343,499			3,319,180
	Basic and diluted per share data:
	Loss from continuing operations
	Basic	$	(0.10	)	$	(0.11	)
	Diluted	$	(0.10	)	$	(0.11	)
	Income from discontinued operations
	Basic	$	—		$	—
	Diluted	$	—		$	—
	Net loss
	Basic	$	(0.10	)	$	(0.11	)
	Diluted	$	(0.10	)	$	(0.11	)
		Six Months Ended
		December 31,
		2013			2012
	Numerators for basic and diluted per share data:
	Loss from continuing operations	$	(320,000	)	$	(418,000	)
	Income from discontinued operations		194,000			53,000
	Net loss	$	(126,000	)	$	(365,000	)
	Denominators for basic and diluted per share data:
	Basic:
	Weighted average common shares outstanding		3,344,098			3,299,379
	Shares used in the computation of basic per share data		3,344,098			3,299,379
	Diluted:
	Shares used in the computation of basic per share data		3,344,098			3,299,379
	Net shares assumed issued using the treasury stock method for outstanding common stock options		0			0
	Shares used in the computation of diluted per share data		3,344,098			3,299,379
	Basic and diluted per share data:
	Loss from continuing operations
	Basic	$	(0.10	)	$	(0.13	)
	Diluted	$	(0.10	)	$	(0.13	)
	Income from discontinued operations
	Basic	$	0.06		$	0.02
	Diluted	$	0.06		$	0.02
	Net loss
	Basic	$	(0.04	)	$	(0.11	)
	Diluted	$	(0.04	)	$	(0.11	)
	All outstanding options to purchase shares of our common stock, as described in Note 9, are not included in the calculation of diluted loss per share due to their anti-dilutive effect.

BANK_DEBT

BANK DEBT	6 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
BANK DEBT	'
	NOTE 5. BANK DEBT
	In February 2011, we entered into a credit facility agreement with Union Bank, N.A. that provided for the following:
		●	A revolving credit line of up to $1.5 million in borrowing availability, under which no amounts were borrowed;
		●	A non-revolving credit line of up to $350,000 in borrowing availability for the purchase of equipment, which expired unused on February 4, 2012; and
		●	A term loan of $1.25 million, the outstanding balance of which, amounting to $685,000, was repaid in full on September 24, 2012, as discussed further below.
	On August 30, 2012, we notified the bank of our intent to terminate the credit facility agreements and on September 24, 2012, we repaid the entire principal balance of the term loan, amounting to $685,000, and the credit facility agreements were terminated.
	As a result of the foregoing, we no longer have a credit facility with a financial institution.

DISCONTINUED_OPERATIONS_AND_RE

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE	6 Months Ended
	Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE	'
	NOTE 6. DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE
	In February 2012, we completed the sale of our fractional horsepower motor product line, operating under the name Pro-Dex Astromec (“Astromec”) and located in Carson City, Nevada, to SL Montevideo Technology, Inc. (“MTI”), a wholly owned subsidiary of SL Industries, Inc., pursuant to an Asset Purchase Agreement (the “APA”).
	Under the terms of the APA, we may receive earnout payments based on revenues generated from the sale of (i) Astromec products and (ii) MTI products to Astromec prospects (defined in the APA) (collectively, the “Earnout Sales Base”). Such earnout payments, if and when earned, are paid by MTI to us within 30 days following the end of each of our fiscal quarters during the three years subsequent to the February 2012 closing date, and amount to 6%, 4% and 2% of the Earnout Sales Base in the first, second and third such years, respectively. The earnout payments are recognized in the quarter in which we become entitled to receive them. We recognized income from earnout payments of $41,000 and $45,000 for the three months ended December 31, 2013 and 2012, respectively, and $70,000 and $92,000  for the six months ended December 31, 2013 and 2012, respectively.   We have recognized an aggregate of $301,000 in income from such earnout payments since the February 2012 closing date.
	In addition, as a result of the sale of the Astromec product line, we listed for sale the land and building constituting the facility in Carson City, Nevada, which was presented as real estate held for sale in the June 30, 2013 consolidated balance sheet with an aggregate carrying amount of $733,000. On April 22, 2013, we entered into a Purchase Agreement with Aesthetic and Reconstructive Technologies, Inc., a Nevada corporation, whereby we agreed to sell the Carson City facility described above. On July 5, 2013, we completed the sale and closed the Purchase Agreement in conformity with its terms. The sales price of the property was $980,000, of which we received net proceeds of $900,000, after deductions for expenses related to the sale, primarily consisting of broker commissions and fees, aggregating approximately $80,000, resulting in a gain of $167,000.
	Based on the foregoing, and in conformity with applicable accounting guidance, the Astromec product line qualifies as a discontinued operation. Accordingly, financial results of Astromec have been reported as discontinued operations in the accompanying consolidated statements of operations for all periods presented. Information regarding revenue and operating results of Astromec included in discontinued operations is as follows:
		Three Months Ended December 31,
		2013		2012
	Revenues	$	41,000	$	45,000
	Income before provision for income taxes	$	36,000	$	37,000
		Six Months Ended December 31,
		2013		2012
	Revenues	$	70,000	$	92,000
	Income before provision for income taxes	$	230,000	$	78,000
	Information regarding Astromec assets and liabilities included in the accompanying consolidated balance sheets is as follows:
		31-Dec-13		30-Jun-13
	Accounts receivable	$	41,000	$	31,000
	Accrued expenses	$	2,000	$	5,000

INCOME_TAXES

INCOME TAXES	6 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	NOTE 7. INCOME TAXES
	Deferred income taxes are provided on a liability method whereby deferred tax assets and liabilities are recognized for temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Significant management judgment is required in determining our provision for income taxes and the recoverability of our deferred tax assets. Such determination is based primarily on our historical taxable income or loss, with some consideration given to our estimates of future taxable income or loss by jurisdictions in which we operate and the period over which our deferred tax assets would be recoverable. Due to cumulative taxable losses during the past three years, we maintained a valuation allowance of $3.4 million against our deferred tax assets as of June 30, 2013.
	As of December 31, 2013, we have accrued $364,000 of unrecognized tax benefits related to federal and state income tax matters. The amount that would reduce the Company’s income tax expense if recognized and result in a corresponding decrease in the Company’s effective tax rate is $47,000.
	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
	Balance at July 1, 2013	$	347,000
	Additions based on tax positions related to the current year		17,000
	Additions for tax positions of prior years
	Reductions for tax positions of prior years
	Balance at December 31, 2013	$	364,000
	We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense when applicable. As of December 31, 2013, no interest or penalties applicable to our unrecognized tax benefits have been accrued since we have sufficient tax attributes available to fully offset any potential assessment of additional tax.
	Pro-Dex and its subsidiaries are subject to U.S. federal income tax, as well as income tax of multiple state tax jurisdictions. We are currently open to audit under the statute of limitations by the Internal Revenue Service for the years ended June 30, 2011 and later. Our state income tax returns are open to audit under the statute of limitations for the years ended June 30, 2010 and later. We do not anticipate a significant change to the total amount of unrecognized tax benefits within the next 12 months.

COMMON_STOCK

COMMON STOCK	6 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
COMMON STOCK	'
	NOTE 8. COMMON STOCK
	Rights Offering
	On December 17, 2013, we publicly announced plans to complete a rights offering to existing holders of our Common Stock and filed a preliminary Form S-3 with the Securities and Exchange Commission. Upon completion of the rights offering, we expect to receive gross proceeds of approximately $3,000,000 before expenses, subject to reduction by us in our sole discretion as we may deem advisable to preserve our use of tax attributes such as net operating loss carryforwards or for other reasons. We have received a standby commitment from AO Partners, LLC and Farnam Street Capital, Inc. (each a beneficial shareholder of our common stock; each a “Standby Purchaser” and collectively the “Standby Purchasers”) to purchase any and all shares of Common Stock that are not subscribed for by shareholders in connection with the rights offering, subject to reduction by us as described above.  Nicholas J. Swenson, one of our directors, is the Managing Member of AO Partners and, in such capacity, has the power to direct the affairs of AO Partners.  Raymond E. Cabillot, also one of our directors, is Chief Executive Officer and a director of Farnam Street Capital and, in such capacity, has the power to direct the affairs of Farnam Street Capital.  No fees or other consideration will be paid by us to the Standby Purchasers in exchange for their commitment to purchase any and all unsubscribed shares of Common Stock following the rights offering.
	The rights offering will be made through a distribution to our existing shareholders of non-transferable subscription rights to purchase their pro rata portion of newly issued shares of Common Stock. The subscription price has not yet been determined but is expected to be based on a percentage discount of the closing market price of the Common Stock, as reported by the NASDAQ Capital Market, on the latest practicable date prior to the launch of the rights offering. The record date for the distribution of the rights and the dates for both the subscription period and the expiration of the rights offering will be included in the final prospectus that will be filed with the Securities and Exchange Commission (“SEC”).
	We intend to use the net proceeds from the Rights Offering to pursue strategic opportunities that may present themselves from time to time or, if not used to pursue strategic opportunities, for working capital and general corporate purposes, including to fund ongoing research and development and product initiatives.  Also, to the extent net proceeds of the Rights Offering are not deployed, some of the funds may be invested in accordance with the terms of our Surplus Capital Investment Policy.
	Share Repurchase Program
	In September 2013, our Board approved a share repurchase program authorizing the Company, at the direction of the Investment Committee of the Board, to repurchase up to 750,000 shares of our common stock under parameters to be determined by the Investment Committee. The repurchase program has no stated expiration date and there have been no purchases under the program.

SHAREBASED_COMPENSATION

SHARE-BASED COMPENSATION	6 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
SHARE-BASED COMPENSATION	'
	NOTE 9. SHARE-BASED COMPENSATION
	We have two equity compensation plans, the Second Amended and Restated 2004 Stock Option Plan (the “Employees Stock Option Plan”) and the Amended and Restated 2004 Directors Stock Option Plan (the “Directors Stock Option Plan”) (collectively, the “Stock Option Plans”), pursuant to which (i) options to purchase shares of common stock, or (ii) restricted shares of common stock, may be granted up to an aggregate amount of 1,333,333 common shares, with 1,066,667 and 266,666 shares distributed between the Employees Stock Option Plan and the Directors Stock Option Plan, respectively. The Stock Option Plans are substantially similar, providing for a strike price equal to the  closing price for a share of our common stock as of the last business day immediately prior to the grant date, vesting periods as determined by the Board for the Employees Stock Option Plan and six months for the Directors Stock Option Plan, and terms of up to ten years, subject to forfeit 30 days after the holder ceases to be an employee or 90 days after the holder ceases to be director, as the case may be. At December   31, 2013, 506,105 and 173,334 shares under the Employees Stock Option Plan and the Directors Stock Option Plan, respectively, are   available to grant in future years. Share-based compensation expense under the Stock Option Plans for the three months ended December 31, 2013 and 2012 was $12,000 and $36,000, respectively, and for the six months ended December 31, 2013 and 2012 was $31,000 and $65,000, respectively.
	Stock Options
	The following assumptions were used in the calculation of share-based compensation expense for options granted during the three and six months ended December 31, 2012:
	Dividend rate	None
	Price volatility	87%
	Risk-free interest rate	0.90%
	Expected life	6.0 years
	No options were granted during the three or six months ended December 31, 2013.
	As of December 31, 2013, there was an aggregate of $34,000 of unrecognized compensation cost under the Stock Option Plans related to 43,000 non-vested outstanding stock options with a per share weighted average value of $1.80. The unrecognized expense is anticipated to be recognized on a straight-line basis over a weighted average period of 1.4 years. Following is a summary of stock option activity for the six months ended December 31, 2013 and 2012:
				2013						2012
							Weighted-						Weighted-
							Average						Average
							Exercise						Exercise
			Shares			Price			Shares			Price
				292,504		$	2.35			591,672		$	2.48
	Outstanding at beginning of period
	Granted			—			—			35,000			1.73
	Exercised			(804	)		1.8			(33,334	)		1.5
	Forfeited			(100,306	)		2.34			(13,334	)		7.74
	Outstanding at end of period			191,394		$	2.36			580,004		$	2.37
	Exercisable at end of period			148,061		$	2.53			250,976		$	2.96
	Weighted-average fair value per option granted during the period					$	—					$	1.25
	Following is a summary of information regarding options outstanding and options exercisable at December 31, 2013:
							Options Outstanding								Options Exercisable
							Average			Average			Aggregate				Average		Average		Aggregate
																	Remaining
	Range of			Number			Contractual			Exercise			Intrinsic		Number		Contractual		Exercise		Intrinsic
	Exercise Price			Outstanding			Life			Price			Value		Outstanding		Life		Price		Value
	$0 to $2.50				169,725			7.86		$	1.87		$	95,546		126,392		7.68	$	1.89	$	67,971
	$2.51 to $5.00				3,334			3.38			4.38			—		3,334		3.38		4.38		—
	$5.01 to $7.50				10,001			0.49			5.61			—		10,001		0.49		5.61		—
	$7.51 to $10.00				8,334			2.02			7.65			—		8,334		2.02		7.65		—
	Total				191,394			7.14		$	$2.36		$	95,546		148,061		6.78	$	2.53	$	67,971
	Restricted Stock
	The following is a summary of restricted share activity for the six months ended December 31, 2013 and 2012:
			2013						2012
			Shares			Weighted-			Shares			Weighted-
						Average						Average
						Grant Date						Grant Date
						Fair Value						Fair Value
	Outstanding at beginning of year			32,500		$	1.73			—
	Granted			—			—			35,000		$	1.73
	Vested			(9,166	)		1.73			—			—
	Forfeited			(6,667	)		1.73			(2,500	)		1.73
	Outstanding at end of period			16,667		$	1.73			32,500		$	1.73
	As of December 31, 2013, there was $19,000 in unrecognized compensation cost related to non-vested outstanding restricted shares.
	The unrecognized expense is anticipated to be amortized over the next 1.7 years.

MAJOR_CUSTOMERS

MAJOR CUSTOMERS	6 Months Ended
	Dec. 31, 2013
Risks and Uncertainties [Abstract]	'
MAJOR CUSTOMERS	'
	NOTE 10. MAJOR CUSTOMERS
	Information with respect to two customers who accounted for sales in excess of 10% of our total sales in either of the three-month periods or either of the six-month periods ended December 31, 2013 or 2012 is as follows:
		As of and for the three months ended December 31,
		2013										2012
		Sales		Percent of			Accounts		Percent of			Sales		Percent of			Accounts		Percent of
				Total			Receivable		Total					Total			Receivable		Total
	Customer 1	$	1,296,000		49	%	$	841,000		53	%	$	1,136,000		38	%	$	432,000		32	%
	Customer 2	$	97,000		4	%	$	9,000		1	%	$	372,000		12	%	$	124,000		11	%
		As of and for the six months ended December 31,
		2013										2012
		Sales		Percent of			Accounts		Percent of			Sales		Percent of			Accounts		Percent of
				Total			Receivable		Total					Total			Receivable		Total
	Customer 1	$	2,393,000		46	%	$	841,000		53	%	$	3,072,000		47	%	$	432,000		32	%

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 11. COMMITMENTS AND CONTINGENCIES
	Change of Control Agreements
	We have Change of Control Agreements with our Chief Executive Officer and Chief Financial Officer, Harold A. Hurwitz, and our Chief Operating Officer, Richard L. Van Kirk.  The Change of Control Agreements provide that, if the individual’s employment with us involuntarily terminates (as such term is defined in the Change of Control Agreements) within 12 months after a change of control (also as such term is defined in the Change of Control Agreements), the individual will receive, subject to signing a release of claims, (i) a lump sum amount equal to 30 weeks base compensation of the individual at the time of such termination and (ii) 100% Company-paid insurance coverage as provided to the individual immediately prior to his termination of employment for a period equal to the earlier of (i) 12 months following termination or (ii) until the individual becomes covered under another employer’s insurance plan. In addition, the individual shall be entitled to receive bonus or compensation award payments, if any, in accordance with the terms of our incentive compensation plans in which the individual was an eligible participant at the time of the termination. No changes of control have taken place that would result in the potential payment of benefits under the terms of the Change of Control Agreements as described herein.  The Change of Control Agreements expire in July 2014.
	Legal Matters
	In February 2011, we became aware of a report entitled “Site Discovery Report, Southeast Santa Ana Project DTSC – Cypress Region,” dated February 2010 (the “Report”), that was prepared by the Cypress regional office of the Cal/EPA Department of Toxic Substances Control (“DTSC”) for Region 9 of the U.S. Environmental Protection Agency (“USEPA”) under an agreement between the two agencies. The purpose of the Report was to identify sites within an area of southeast Santa Ana, California that may be sources of groundwater contamination previously detected in that area. The Report identified 25 sites, including our former Santa Ana site, for further screening by DTSC staff. DTSC has informed us that no further evaluation of our former site has taken place subsequent to the Report’s issuance. It is uncertain whether future developments, if any, from DTSC’s screening process would have any application to our former site.
	In general, we are from time to time a party to various legal proceedings incidental to our business, none of which we consider may be material. There can be no certainty, however, that we may not ultimately incur liability or that such liability will not be material and adverse.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	NOTE 12. FAIR VALUE MEASUREMENTS
	Fair value is measured based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
	Cash and cash equivalents: The carrying value of cash and cash equivalents is considered to be representative of their fair values based on the short term nature of these instruments. As such, cash and cash equivalents are classified within Level 1 of the valuation hierarchy.
	Investments: Investments consist of marketable equity securities of publicly held companies. As such, investments are classified within Level 1 of the valuation hierarchy.
	Although the methods above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values, we believe its valuation methods are appropriate.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 13. SUBSEQUENT EVENTS
	We have evaluated events or transactions that occurred after the balance sheet date of December 31, 2013 and have identified no such events or transactions which required adjustment to, or disclosure in, these Condensed Consolidated Financial Statements other than as presented in such financial statements and the Notes thereto.

BASIS_OF_PRESENTATION_Policies

BASIS OF PRESENTATION (Policies)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Recent Accounting Standards	'
	In August 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” that sets forth circumstances in which an unrecognized tax benefit, generally reflecting the difference between a tax position taken or expected to be taken on a company’s income tax return and the benefit recognized on its financial statements, should be presented in the company’s financial statements as a liability rather than as a reduction of a deferred tax asset. The ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, with early adoption permitted. The adoption of these provisions is not expected to have a material impact on the consolidated financial statements of the Company.

COMPOSITION_OF_CERTAIN_FINANCI1

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Tables)	6 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Summary of Inventories	'
		31-Dec-13		30-Jun-13
	Raw materials / purchased components	$	1,538,000	$	1,640,000
	Work in process		499,000		572,000
	Sub-assemblies / Finished components		1,139,000		1,291,000
	Finished goods		376,000		331,000
	Total inventories	$	3,552,000	$	3,834,000
Summary of Investments	'
		31-Dec-13		30-Jun-13
	Marketable equity securities	$	903,000	$	370,000

WARRANTY_Tables

WARRANTY (Tables)	6 Months Ended
	Dec. 31, 2013
Product Warranties Disclosures [Abstract]	'
Schedule of accrual warranty costs	'
		Three Months Ended December 31,
		2013			2012
	Balances, beginning of period	$	229,000		$	585,000
	Accruals during the period		47,000			38,000
	Changes in estimates of prior period accruals		(31,000	)		(16,000	)
	Warranty expenditures		(45,000	)		(246,000	)
	Balances, end of period	$	200,000		$	361,000
		Six Months Ended December 31,
		2013			2012
	Balances, beginning of period	$	321,000		$	526,000
	Accruals during the period		96,000			186,000
	Changes in estimates of prior period accruals		(67,000	)		(56,000	)
	Warranty expenditures		(150,000	)		(295,000	)
	Balances, end of period	$	200,000		$	361

NET_INCOME_LOSS_PER_SHARE_Tabl

NET INCOME (LOSS) PER SHARE (Tables)	6 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Schedule of weighted average shares outstanding calculation of basic and diluted per share	'
		Three Months Ended
		December 31,
		2013			2012
	Numerators for basic and diluted per share data:
	Loss from continuing operations	$	(338,000	)	$	(364,000	)
	Income from discontinued operations		—			16,000
	Net loss	$	(338,000	)	$	(348,000	)
	Denominators for basic and diluted per share data:
	Basic:
	Weighted average common shares outstanding		3,343,499			3,319,180
	Shares used in the computation of basic per share data		3,343,499			3,319,180
	Diluted:
	Shares used in the computation of basic per share data		3,343,499			3,319,180
	Net shares assumed issued using the treasury stock method for outstanding common stock options		—			—
	Shares used in the computation of diluted per share data		3,343,499			3,319,180
	Basic and diluted per share data:
	Loss from continuing operations
	Basic	$	(0.10	)	$	(0.11	)
	Diluted	$	(0.10	)	$	(0.11	)
	Income from discontinued operations
	Basic	$	—		$	—
	Diluted	$	—		$	—
	Net loss
	Basic	$	(0.10	)	$	(0.11	)
	Diluted	$	(0.10	)	$	(0.11	)
		Six Months Ended
		December 31,
		2013			2012
	Numerators for basic and diluted per share data:
	Loss from continuing operations	$	(320,000	)	$	(418,000	)
	Income from discontinued operations		194,000			53,000
	Net loss	$	(126,000	)	$	(365,000	)
	Denominators for basic and diluted per share data:
	Basic:
	Weighted average common shares outstanding		3,344,098			3,299,379
	Shares used in the computation of basic per share data		3,344,098			3,299,379
	Diluted:
	Shares used in the computation of basic per share data		3,344,098			3,299,379
	Net shares assumed issued using the treasury stock method for outstanding common stock options		0			0
	Shares used in the computation of diluted per share data		3,344,098			3,299,379
	Basic and diluted per share data:
	Loss from continuing operations
	Basic	$	(0.10	)	$	(0.13	)
	Diluted	$	(0.10	)	$	(0.13	)
	Income from discontinued operations
	Basic	$	0.06		$	0.02
	Diluted	$	0.06		$	0.02
	Net loss
	Basic	$	(0.04	)	$	(0.11	)
	Diluted	$	(0.04	)	$	(0.11	)

DISCONTINUED_OPERATIONS_AND_RE1

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Tables)	6 Months Ended
	Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of revenue and operating results of Astromec	'
		Three Months Ended December 31,
		2013		2012
	Revenues	$	41,000	$	45,000
	Income before provision for income taxes	$	36,000	$	37,000
		Six Months Ended December 31,
		2013		2012
	Revenues	$	70,000	$	92,000
	Income before provision for income taxes	$	230,000	$	78,000
Schedule of Astromec assets and liabilities	'
		31-Dec-13		30-Jun-13
	Accounts receivable	$	41,000	$	31,000
	Accrued expenses	$	2,000	$	5,000

INCOME_TAXES_Tables

INCOME TAXES (Tables)	6 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of unrecognized tax benefits	'
	Balance at July 1, 2013	$	347,000
	Additions based on tax positions related to the current year		17,000
	Additions for tax positions of prior years
	Reductions for tax positions of prior years
	Balance at December 31, 2013	$	364,000

SHAREBASED_COMPENSATION_Tables

SHARE-BASED COMPENSATION (Tables)	6 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of weighted average assumptions	'
	Dividend rate	None
	Price volatility	87%
	Risk-free interest rate	0.90%
	Expected life	6.0 years
Schedule of summary of stock option activity	'
				2013							2012
							Weighted-								Weighted-
							Average								Average
							Exercise								Exercise
			Shares			Price				Shares				Price
				292,504		$	2.35				591,672			$	2.48
	Outstanding at beginning of period
	Granted			—			—				35,000				1.73
	Exercised			(804	)		1.8				(33,334	)			1.5
	Forfeited			(100,306	)		2.34				(13,334	)			7.74
	Outstanding at end of period			191,394		$	2.36				580,004			$	2.37
	Exercisable at end of period			148,061		$	2.53				250,976			$	2.96
	Weighted-average fair value per option granted during the period					$	—							$	1.25
Schedule of options outstanding and options exercisable	'
							Options Outstanding										Options Exercisable
							Average				Average				Aggregate				Average		Average		Aggregate
																			Remaining
	Range of			Number			Contractual				Exercise				Intrinsic		Number		Contractual		Exercise		Intrinsic
	Exercise Price			Outstanding			Life				Price				Value		Outstanding		Life		Price		Value
	$0 to $2.50				169,725			7.86			$	1.87			$	95,546		126,392		7.68	$	1.89	$	67,971
	$2.51 to $5.00				3,334			3.38				4.38				—		3,334		3.38		4.38		—
	$5.01 to $7.50				10,001			0.49				5.61				—		10,001		0.49		5.61		—
	$7.51 to $10.00				8,334			2.02				7.65				—		8,334		2.02		7.65		—
	Total				191,394			7.14			$	$2.36			$	95,546		148,061		6.78	$	2.53	$	67,971
Schedule of restricted share activity	'
			2013					2012
			Shares			Weighted-		Shares				Weighted-
						Average						Average
						Grant Date						Grant Date
						Fair Value						Fair Value
	Outstanding at beginning of year			32,500		$	1.73		—
	Granted			—			—		35,000			$	1.73
	Vested			(9,166	)		1.73		—				—
	Forfeited			(6,667	)		1.73		(2,500	)			1.73
	Outstanding at end of period			16,667		$	1.73		32,500			$	1.73

MAJOR_CUSTOMERS_Tables

MAJOR CUSTOMERS (Tables)	6 Months Ended
	Dec. 31, 2013
Risks and Uncertainties [Abstract]	'
Schedule of sales by major customers	'
		As of and for the three months ended December 31,
		2013										2012
		Sales		Percent of			Accounts		Percent of			Sales		Percent of			Accounts		Percent of
				Total			Receivable		Total					Total			Receivable		Total
	Customer 1	$	1,296,000		49	%	$	841,000		53	%	$	1,136,000		38	%	$	432,000		32	%
	Customer 2	$	97,000		4	%	$	9,000		1	%	$	372,000		12	%	$	124,000		11	%
		As of and for the six months ended December 31,
		2013										2012
		Sales		Percent of			Accounts		Percent of			Sales		Percent of			Accounts		Percent of
				Total			Receivable		Total					Total			Receivable		Total
	Customer 1	$	2,393,000		46	%	$	841,000		53	%	$	3,072,000		47	%	$	432,000		32	%

COMPOSITION_OF_CERTAIN_FINANCI2

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Raw materials / purchased components	$1,538,000	$1,640,000
Work in process	499,000	572,000
Sub-assemblies / finished components	1,139,000	1,291,000
Finished goods	376,000	331,000
Total inventories	$3,552,000	$3,834,000

COMPOSITION_OF_CERTAIN_FINANCI3

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 1) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Marketable equity securities	$903,000	$370,000

COMPOSITION_OF_CERTAIN_FINANCI4

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details Textuals) (USD $)	6 Months Ended	12 Months Ended
	Dec. 31, 2013	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Marketable security cost	$694,000	$365,000
Marketable security unrealized, gain	209,000	5,000
Marketable security unrealized, loss	'	'

WARRANTY_Details

WARRANTY (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]	'	'	'	'
Balances, beginning of period	$229,000	$585,000	$321,000	$526,000
Accruals during the period	47,000	38,000	96,000	186,000
Changes in estimates of prior period accruals	-31,000	-16,000	-67,000	-56,000
Warranty expenditures	-45,000	-246,000	-150,000	-295,000
Balances, end of period	$200,000	$361,000	$200,000	$361,000

WARRANTY_Details_Textuals

WARRANTY (Details Textuals) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Jun. 30, 2012
Product Warranties Disclosures [Abstract]	'	'	'	'	'	'	'	'
Warranty reserves related to continuing operations	$200,000	$361,000	$200,000	$361,000	$229,000	$321,000	$585,000	$526,000
Warranty expense related to continuing operations	$16,000	$22,000	$29,000	$130,000	'	'	'	'

NET_INCOME_LOSS_PER_SHARE_Deta

NET INCOME (LOSS) PER SHARE (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Numerators for basic and diluted per share data:	'	'	'	'
Loss from continuing operations	($338,000)	($364,000)	($320,000)	($418,000)
Income from discontinued operations	'	16,000	194,000	53,000
Net loss	($338,000)	($348,000)	($126,000)	($365,000)
Basic:	'	'	'	'
Weighted average common shares outstanding	3,343,499	3,319,180	3,344,098	3,299,379
Shares used in the computation of basic per share data	3,343,499	3,319,180	3,344,098	3,299,379
Diluted:	'	'	'	'
Shares used in the computation of basic per share data	3,343,499	3,319,180	3,344,098	3,299,379
Net shares assumed issued using the treasury stock method for outstanding common stock options	'	'	0	0
Shares used in the computation of diluted per share data	3,343,499	3,319,180	3,344,098	3,299,379
Loss from continuing operations	'	'	'	'
Basic (in dollars per share)	($0.10)	($0.11)	($0.10)	($0.13)
Diluted (in dollars per share)	($0.10)	($0.11)	($0.10)	($0.13)
Income from discontinued operations	'	'	'	'
Basic (in dollars per share)	'	'	$0.06	$0.02
Diluted (in dollars per share)	'	'	$0.06	$0.02
Net loss	'	'	'	'
Basic (in dollars per share)	($0.10)	($0.11)	($0.04)	($0.11)
Diluted (in dollars per share)	($0.10)	($0.11)	($0.04)	($0.11)

BANK_DEBT_Details_Textuals

BANK DEBT (Details Textuals) (Union Bank, USD $)	Feb. 28, 2011	Feb. 28, 2011	Sep. 24, 2012	Feb. 28, 2011
	Revolving Credit Facility	Non Revolving Credit Facility	Secured Debt	Secured Debt
Line of Credit Facility [Line Items]	'	'	'	'
Maximum amount of borrowing under the credit line	$1,500,000	$350,000	'	$1,250,000
Repayment of term loan	'	'	$685,000	'
Expiraton date	'	4-Feb-12	'	'

DISCONTINUED_OPERATIONS_AND_RE2

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Details) (Astromec, USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Astromec	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Revenues	$41,000	$45,000	$70,000	$92,000
Income before provision for income taxes	$36,000	$37,000	$230,000	$78,000

DISCONTINUED_OPERATIONS_AND_RE3

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Details 2) (Astromec, USD $)	Dec. 31, 2013	Jun. 30, 2013
Astromec	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'
Accounts receivable	$41,000	$31,000
Accrued expenses	$2,000	$5,000

DISCONTINUED_OPERATIONS_AND_RE4

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Details Textuals) (USD $)	6 Months Ended			3 Months Ended		6 Months Ended		22 Months Ended	0 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Jul. 05, 2013
				Astromec	Astromec	Astromec	Astromec	Astromec	Aesthetic and Reconstructive Technologies, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'	'	'	'	'
Earnout payments period	'	'	'	'	'	'30 days	'	'	'
Percentage of earnout payments in first quarter	'	'	'	'	'	6.00%	'	'	'
Percentage of earnout payments in second quarter	'	'	'	'	'	4.00%	'	'	'
Percentage of earnout payments in third quarter	'	'	'	'	'	2.00%	'	'	'
Income from earnout payments	'	'	'	$41,000	$45,000	$70,000	$92,000	$301,000	'
Real estate held for sale	'	'	733,000	'	'	'	'	'	'
Proceeds from sale of real estate held for sale	'	'	'	'	'	'	'	'	980,000
Net proceeds from the sale	900,000	'	'	'	'	'	'	'	900,000
Broker commissions and fees	'	'	'	'	'	'	'	'	80,000
Gain on sale of real estate held or sale	$167,000	'	'	'	'	'	'	'	$167,000

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	6 Months Ended
	Dec. 31, 2013
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'
Beginning Balance	$347,000
Additions based on tax positions related to the current year	17,000
Additions for tax positions of prior years	'
Reductions for tax positions of prior years	'
Ending Balance	$364,000

INCOME_TAXES_Details_Textuals

INCOME TAXES (Details Textuals) (USD $)	6 Months Ended
	Dec. 31, 2013	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'	'
Deferred tax assets, valuation allowance	'	$3,400,000
Accrued unrecognized tax benefits related to federal and state income tax	364,000	347,000
Decrease in income tax expenses	$47,000	'

COMMON_STOCK_Details_Textuals

COMMON STOCK (Details Textuals) (USD $)	Sep. 30, 2013	Dec. 17, 2013
		Right offering
Proceeds from issuance of common stock	'	$3,000,000
Maximum number of shares authorized to be repurchased (in shares)	750,000	'

SHAREBASED_COMPENSATION_Detail

SHARE-BASED COMPENSATION (Details)	6 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Dividend rate	'
Price volatility	87.00%
Risk-free interest rate	0.90%
Expected life	'6 years

SHAREBASED_COMPENSATION_Detail1

SHARE-BASED COMPENSATION (Details 2) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Outstanding at beginning of period	292,504	591,672
Granted	'	35,000
Exercised	-804	-33,334
Forfeited	-100,306	-13,334
Outstanding at end of period	191,394	580,004
Exercisable at end of period	148,061	250,976
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]	'	'
Outstanding at beginning of period	$2.35	$2.48
Granted	'	$1.73
Exercised	$1.80	$1.50
Forfeited	$2.34	$7.74
Outstanding at end of period	$2.36	$2.37
Exercisable at end of period	$2.53	$2.96
Weighted-average fair value per option granted during the period	'	$1.25

SHAREBASED_COMPENSATION_Detail2

SHARE-BASED COMPENSATION (Details 3) (USD $)	6 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	191,394
Weighted-Average Remaining Contractual Life	'7 years 1 month 21 days
Weighted-Average Exercise Price	$2.36
Aggregate Intrinsic Value	$95,546
Number Outstanding	148,061
Weighted-Average Remaining Contractual Life	'6 years 9 months 11 days
Weighted-Average Exercise Price	$2.53
Aggregate Intrinsic Value	67,971
$0 to $2.50	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	169,725
Weighted-Average Remaining Contractual Life	'7 years 10 months 10 days
Weighted-Average Exercise Price	$1.87
Aggregate Intrinsic Value	95,546
Number Outstanding	126,392
Weighted-Average Remaining Contractual Life	'7 years 8 months 5 days
Weighted-Average Exercise Price	$1.89
Aggregate Intrinsic Value	67,971
$2.51 to $5.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	3,334
Weighted-Average Remaining Contractual Life	'3 years 4 months 17 days
Weighted-Average Exercise Price	$4.38
Aggregate Intrinsic Value	'
Number Outstanding	3,334
Weighted-Average Remaining Contractual Life	'3 years 4 months 17 days
Weighted-Average Exercise Price	$4.38
Aggregate Intrinsic Value	'
$5.01 to $7.50	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	10,001
Weighted-Average Remaining Contractual Life	'5 months 27 days
Weighted-Average Exercise Price	$5.61
Aggregate Intrinsic Value	'
Number Outstanding	10,001
Weighted-Average Remaining Contractual Life	'5 months 27 days
Weighted-Average Exercise Price	$5.61
Aggregate Intrinsic Value	'
$7.51 to $10.00	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	8,334
Weighted-Average Remaining Contractual Life	'2 years 7 days
Weighted-Average Exercise Price	$7.65
Aggregate Intrinsic Value	'
Number Outstanding	8,334
Weighted-Average Remaining Contractual Life	'2 years 7 days
Weighted-Average Exercise Price	$7.65
Aggregate Intrinsic Value	'

SHAREBASED_COMPENSATION_Detail3

SHARE-BASED COMPENSATION (Details 4) (Restricted shares, USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Restricted shares	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'
Outstanding at beginning of year	32,500	'
Granted	'	35,000
Vested	-9,166	'
Forfeited	-6,667	-2,500
Outstanding at end of period	16,667	32,500
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'	'
Outstanding at beginning of year	$1.73	'
Granted	'	$1.73
Vested	$1.73	'
Forfeited	$1.73	$1.73
Outstanding at end of period	$1.73	$1.73

SHAREBASED_COMPENSATION_Detail4

SHARE-BASED COMPENSATION (Details Textuals) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated share-based compensation expense	$12,000	$36,000	$31,000	$65,000
Unrecognized compensation cost	34,000	'	34,000	'
Numbers of nonvested stock options	43,000	'	43,000	'
Weighted average value of non vested stock options (in dollars per share)	$1.80	'	$1.80	'
Unrecognized expensse recognized weighted average period	'	'	'1 year 4 months 24 days	'
Restricted shares	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Numbers of shares authorized	1,333,333	'	1,333,333	'
Description of vesting period	'	'	'	'
			Vesting periods as determined by the Board for the Employees Stock Option Plan and six months for the Directors Stock Option Plan, and terms of up to ten years, subject to forfeit 30 days after the holder ceases to be an employee or 90 days after the holder ceases to be director, as the case may be.
Unrecognized expensse recognized weighted average period	'	'	'1 year 8 months 12 days	'
Unrecognized compensation cost	$19,000	'	$19,000	'
Restricted shares | Employees Stock Option Plan	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Numbers of shares authorized	1,066,667	'	1,066,667	'
Forfeiture period of stock option in case of cessation of employment	'	'	'30 days	'
Numbers of shares available to grant	506,105	'	506,105	'
Restricted shares | Directors Stock Option Plan	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Numbers of shares authorized	266,666	'	266,666	'
Forfeiture period of stock option in case of cessation of employment	'	'	'90 days	'
Numbers of shares available to grant	173,334	'	173,334	'

MAJOR_CUSTOMERS_Details

MAJOR CUSTOMERS (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Percentage of concentrations risk	'	'	10.00%	'
Sales | Customer 1	'	'	'	'
Sales	$1,296,000	$1,136,000	$2,393,000	$3,072,000
Percentage of concentrations risk	49.00%	38.00%	46.00%	47.00%
Sales | Customer 2	'	'	'	'
Sales	97,000	372,000	'	'
Percentage of concentrations risk	4.00%	12.00%	'	'
Accounts Receivable | Customer 1	'	'	'	'
Accounts Receivable	841,000	432,000	841,000	432,000
Percentage of total accounts receivable	53.00%	32.00%	53.00%	32.00%
Accounts Receivable | Customer 2	'	'	'	'
Accounts Receivable	$9,000	$124,000	$9,000	$124,000
Percentage of total accounts receivable	1.00%	11.00%	1.00%	11.00%

MAJOR_CUSTOMERS_Details_Textua

MAJOR CUSTOMERS (Details Textuals)	6 Months Ended
	Dec. 31, 2013
Risks and Uncertainties [Abstract]	'
Percentage of sales concentrations risk	10.00%

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details Textuals)	6 Months Ended
	Dec. 31, 2013
	N
Loss Contingencies [Line Items]	'
Number of agencies under the agreement	2
Number of sites as per the report	25
Separation Agreement	'
Loss Contingencies [Line Items]	'
Employees involuntary termination time period	'12 months
Base compensation period	'
	30 weeks
Employees insurance coverage cost	100.00%